Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,948 | 1,247 | 99.5% |
| Education | $102.83 | 11 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,588 | 123 | $0 (2024) |
| Novo Nordisk Inc | $1,958 | 148 | $0 (2024) |
| Lilly USA, LLC | $1,956 | 134 | $0 (2024) |
| PFIZER INC. | $1,568 | 131 | $0 (2024) |
| ABBVIE INC. | $1,452 | 91 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,397 | 95 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $902.65 | 48 | $0 (2023) |
| Merck Sharp & Dohme LLC | $893.86 | 76 | $0 (2024) |
| GlaxoSmithKline, LLC. | $687.28 | 48 | $0 (2024) |
| Amgen Inc. | $576.92 | 37 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,976 | 169 | Novo Nordisk Inc ($364.46) |
| 2023 | $2,771 | 177 | ABBVIE INC. ($497.46) |
| 2022 | $1,605 | 96 | ABBVIE INC. ($318.96) |
| 2021 | $2,143 | 131 | Lilly USA, LLC ($373.20) |
| 2020 | $1,776 | 125 | AstraZeneca Pharmaceuticals LP ($287.28) |
| 2019 | $2,699 | 180 | AstraZeneca Pharmaceuticals LP ($533.27) |
| 2018 | $2,341 | 181 | Novo Nordisk Inc ($359.52) |
| 2017 | $2,738 | 199 | AstraZeneca Pharmaceuticals LP ($598.64) |
All Payment Transactions
1,258 individual payment records from CMS Open Payments — Page 3 of 51
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Diabetes Care | ||||||
| 08/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Neurology | ||||||
| 08/21/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.60 | General |
| Category: Cardiovascular | ||||||
| 08/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: Biological | ||||||
| 08/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.33 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: PAIN | ||||||
| 08/12/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Inflammation | ||||||
| 08/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Diabetes Care | ||||||
| 08/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: DIABETES | ||||||
| 08/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Gastroenterology | ||||||
| 08/01/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.03 | General |
| Category: Obesity | ||||||
| 07/26/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Genetic Disease | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Respiratory | ||||||
| 07/23/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Neuromodulation | ||||||
| 07/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Biological | ||||||
| 07/22/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: HIV | ||||||
| 07/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Cardio-renal | ||||||
| 07/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,235 | 1,743 | $134,644 | $59,526 |
| 2022 | 26 | 1,089 | 1,626 | $116,253 | $34,138 |
| 2021 | 20 | 937 | 1,355 | $100,372 | $38,698 |
| 2020 | 23 | 1,212 | 1,756 | $112,141 | $38,267 |
All Medicare Procedures & Services
92 procedure records from CMS Medicare Utilization — Page 2 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 36 | 37 | $2,960 | $2,533 | 85.6% |
| 82306 | Vitamin d-3 level | Office | 2022 | 44 | 65 | $5,265 | $1,897 | 36.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 80 | 122 | $4,392 | $1,599 | 36.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 82 | 129 | $3,741 | $1,344 | 35.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 63 | 63 | $12,973 | $1,308 | 10.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 43 | 44 | $1,804 | $1,259 | 69.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 64 | 69 | $3,174 | $1,143 | 36.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 60 | 108 | $2,808 | $1,026 | 36.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 56 | 56 | $1,676 | $995.60 | 59.4% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2022 | 61 | 83 | $1,494 | $529.56 | 35.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 87 | 171 | $2,052 | $506.13 | 24.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 11 | 11 | $1,100 | $398.43 | 36.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 12 | 34 | $1,394 | $323.02 | 23.2% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2022 | 15 | 16 | $656.00 | $237.23 | 36.2% |
| 82746 | Folic acid level, serum | Office | 2022 | 14 | 15 | $600.00 | $216.86 | 36.1% |
| 82043 | Urine microalbumin (protein) level | Office | 2022 | 27 | 36 | $576.00 | $206.16 | 35.8% |
| 82728 | Ferritin (blood protein) level | Office | 2022 | 11 | 15 | $555.00 | $201.20 | 36.3% |
| 84466 | Transferrin (iron binding protein) level | Office | 2022 | 11 | 15 | $525.00 | $188.28 | 35.9% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 23 | 31 | $434.00 | $159.43 | 36.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 59 | 71 | $426.00 | $157.62 | 37.0% |
| 80069 | Kidney function blood test panel | Office | 2022 | 15 | 18 | $432.00 | $154.17 | 35.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 17 | 20 | $420.00 | $153.00 | 36.4% |
| 83540 | Iron level | Office | 2022 | 16 | 23 | $414.00 | $146.56 | 35.4% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2022 | 14 | 15 | $375.00 | $133.68 | 35.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 111 | 326 | $57,376 | $18,318 | 31.9% |
About Dr. Teresa Marshall, M.D
Dr. Teresa Marshall, M.D is a Family Medicine healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346257565.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Teresa Marshall, M.D has received a total of $19,051 in payments from pharmaceutical and medical device companies, with $2,976 received in 2024. These payments were reported across 1,258 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($18,948).
As a Medicare-enrolled provider, Marshall has provided services to 4,473 Medicare beneficiaries, totaling 6,480 services with total Medicare billing of $170,629. Data is available for 4 years (2020–2023), covering 92 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Kansas City, MO
- Active Since 08/01/2006
- Last Updated 10/07/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1346257565
Products in Payments
- FARXIGA (Drug) $1,641
- TRULICITY (Drug) $978.40
- JARDIANCE (Drug) $820.65
- Ozempic (Drug) $783.43
- VRAYLAR (Drug) $749.01
- XARELTO (Drug) $560.77
- CHANTIX (Drug) $516.83
- JANUVIA (Drug) $515.16
- MOUNJARO (Drug) $447.12
- SYMBICORT (Drug) $414.88
- ELIQUIS (Drug) $373.10
- INVOKANA (Drug) $341.88
- GEMTESA (Drug) $312.58
- Kerendia (Drug) $301.99
- TRADJENTA (Drug) $295.14
- Victoza (Drug) $283.77
- UBRELVY (Drug) $276.45
- Morphabond ER (Drug) $253.58
- Saxenda (Drug) $250.41
- BELSOMRA (Drug) $240.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Kansas City
Dr. Meredith Levine, M.d, M.D
Family Medicine — Payments: $38,004
Eric Aspinwall, Md, MD
Family Medicine — Payments: $33,048
Dr. Maurice Blodgett, D.o, D.O
Family Medicine — Payments: $30,998
Dr. Blair Thedinger
Family Medicine — Payments: $19,784
Dr. Julie Alvarez, Md, MD
Family Medicine — Payments: $19,673
Michael Simanovsky, M.d, M.D
Family Medicine — Payments: $16,366